Insulet (PODD) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,751.00 |
| Dec 31, 2025 | 1,625.00 |
| Sep 30, 2025 | 1,164.00 |
| Jun 30, 2025 | 1,072.00 |
| Mar 31, 2025 | 720.00 |
| Dec 31, 2024 | 744.00 |
| Sep 30, 2024 | 774.00 |
| Jun 30, 2024 | 761.00 |
| Mar 31, 2024 | 727.00 |
| Dec 31, 2023 | 713.00 |
| Sep 30, 2023 | 558.00 |
| Jun 30, 2023 | 372.00 |
| Mar 31, 2023 | 173.00 |
| Dec 31, 2022 | 333.00 |
| Sep 30, 2022 | 619.00 |
| Jun 30, 2022 | 779.00 |
| Mar 31, 2022 | 1,002.00 |
| Dec 31, 2021 | 970.00 |
| Sep 30, 2021 | 1,030.00 |
| Jun 30, 2021 | 2,141.00 |
| Mar 31, 2021 | 2,646.00 |
| Dec 31, 2020 | 2,551.00 |
| Sep 30, 2020 | 1,988.00 |
| Jun 30, 2020 | 1,488.00 |
| Mar 31, 2020 | 1,065.00 |
| Dec 31, 2019 | 825.00 |
| Sep 30, 2019 | 847.00 |
| Jun 30, 2019 | 1,472.00 |
| Mar 31, 2019 | 1,432.00 |
| Dec 31, 2018 | 1,529.00 |
| Sep 30, 2018 | 1,615.00 |
| Jun 30, 2018 | 1,139.00 |
| Mar 31, 2018 | 1,564.00 |
| Dec 31, 2017 | 2,231.00 |
| Sep 30, 2017 | 2,354.00 |
| Jun 30, 2017 | 2,247.00 |
| Mar 31, 2017 | 2,277.00 |
| Dec 31, 2016 | 1,889.00 |
| Sep 30, 2016 | 1,365.00 |